Journal: bioRxiv
Article Title: Engineered probiotics for local tumor delivery of checkpoint blockade nanobodies
doi: 10.1101/562785
Figure Lengend Snippet: (a) BALB/c mice were implanted subcutaneously with 5×10 6 CT26 cells on both hind flanks and injected with strains genomically expressing a luminescence reporter for more feasible tracking of bacterial population dynamics over time. (b) Mice were dosed with 5×10 6 bacteria of either the non-lysing EcN-lux or SLC-int:PD-L1nb strain and bacterial populations were tracked using IVIS. (c) Mean relative tumor trajectory of mice receiving intratumoral injections of 5×10 6 bacteria of either SLC-int:PD-L1nb or SLC-p15A:PD-L1nb. Arrows indicate days of intratumoral injection (N=6 tumors per group, ** P=0.0065, two-way ANOVA with Bonferroni post-test, error bars represent S.E.M) (d) The absolute slope between day 0 and 6 and between day 7 and 14 (* P = 0.0175, segmented linear regression analysis). (e) Mean relative tumor trajectory of mice receiving intratumoral injections of 5×10 6 bacteria of EcN-lux or SLC-int:PD-L1nb or intraperiotoneal injection of 200ug/mouse of 10F.9G2 mAb. All treatments were administered on day 0 and 4 (N=6-8 tumors per group, ** P=0.0015. two-way ANOVA with Bonferroni post-test, error bars represent S.E.M). (f) Dirty necrosis scores of histology tissue samples from tumors treated with PBS, EcN-lux, SLC-int:PD-L1nb, and anti-PD-L1 mAb (N=6-8 scores per group of biological replicates, ***P=0.007 Mann Whitney Test ordinal non parametric between SLC-int:PD-L1nb and anti-PD-L1 mAb, error bars represent S.E.M).
Article Snippet: Animal experiments were performed on 6-8 week old female BALB/C mice from Taconic with bilateral subcutaneous hind flank tumors from an implanted mouse colorectal cancer cell line CT26, mouse lymphoma cell line A20, or a mouse breast cancer cell line, 4T1.
Techniques: Injection, Expressing, MANN-WHITNEY